Journals / Türk Fertilite Dergisi / 2004 / Cilt: 12 - Sayı: 4

Evaluation of the effects of obesity and polycystic ovary syndrome on glucose metabolism and sex hormone levels

Obesite ve polikistik over sendromunun glikoz metabolizması ve seks hormon düzeyine etkilerinin değerlendirilmesi

Pages
322–328
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Certainly, hyperinsulinemi in patients with polycystic ovary syndrome contribute to androgen production, but, different mechanisms should also be investigated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The existence of insulin resistance in women with polycystic ovary syndrome has been generally accepted, but, the debate is still continuing about whether this is a part of syndrome or is the result of obesity that is usually seen in this patient group.
📊
Key Findings & Data:Institution: Mersin University, School of Medicine, Department of Obstetrics and Gynecology Materials and Methods: Sixty women with polycystic ovary syndrome and 60 age-matched controls without any endocrinopathy were included in the study.
💡
Conclusion & Impact:Certainly, hyperinsulinemi in patients with polycystic ovary syndrome contribute to androgen production, but, different mechanisms should also be investigated.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Obezite · Polikistik yumurtalık sendromu · Gonadal steroid hormonları

Abstract

Aim: The existence of insulin resistance in women with polycystic ovary syndrome has been generally accepted, but, the debate is still continuing about whether this is a part of syndrome or is the result of obesity that is usually seen in this patient group. In this study, we aimed to investigate the effect of obesity on sex hormone levels and glucose metabolism in women with and without polycystic ovary syndrome. Institution: Mersin University, School of Medicine, Department of Obstetrics and Gynecology Materials and Methods: Sixty women with polycystic ovary syndrome and 60 age-matched controls without any endocrinopathy were included in the study. The patients with a body mass index 28 kg/mr and over were regarded to be obese. Insulin levels, glucose tolerance and sex hormone levels were evaluated in these patients. Results: Insulin levels were found higher in women with polycystic ovary syndrome regardless of obesity. Insulin level was higher only in obese patients in the control group. Regardless of obesity; testosterone, androstenedione and dehydroepiandrosterone-sulfate levels were higher than the control group. The sex hormone levels were within the normal range, although the obese control patients had hyperinsulinemia. Conclusion: In our study, hyperandrogenemia with both adrenal and ovarian origin had been found in patients with polycystic ovary syndrome. However, this could not be explained with obesity or hyperinsu linemia, alone. Certainly, hyperinsulinemi in patients with polycystic ovary syndrome contribute to androgen production, but, different mechanisms should also be investigated.

Özet

Amaç: Polikistik over sendromlu kadınlarda periferik insülin direnci varlığı genel olarak kabul görmektedir ancak bunun sendromun bir parçası mı olduğu, yoksa bu hasta grubunda sık gözlenen obesiteden mi kaynaklandığı halen tartışma konusudur. Bu çalışmada, obesitenin, polikistik over sendromu olan veya olmayan hasta gruplarında seks hormon düzeyleri ve glikoz metabolizması üzerindeki etkisini araştırmayı amaçladık. Çalışmanın Yapıldığı Yer: Mersin Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Anabilim Dalı Materyal ve Metod: 60 polikistik over sendromlu hasta ve yaş açısından eşleştirilmiş 60 düzenli adet gören ve herhangi bir endokrinopatisi olmayan kadın çalışmaya dahil edildi. Vücut kitle indeksi 28 kg/m2 ve üzerinde olan hastalar obez kabul edildi. Bu hastalarda insülin düzeyleri, glukoz toleransı ve seks hormon düzeyleri değerlendirildi. Bulgular: Polikistik over sendromu olan kadınlarda obesiteden bağımsız olarak insülin düzeyleri yüksek bulundu. Kontrol grubunda ise sadece obez hastalarda insülin düzeyi yüksekti. Polikistik over sendromlu hastalarda testosteron, androstenedion ve dehidroepiandrosteron-sülfat düzeyleri yine obesiteden bağımsız olarak kontrol grubundan yüksekti. Obez kontrol hastalarında hiperinsülinemi olmasına rağmen seks hormon düzeyleri normal sınırlarda idi. Sonuçlar:Çalışmamızda, PKOS hastalarında hem adrenal hem de over kaynaklı hiperandrojenemi saptandı. Ancak bu durum sadece obesite veya sadece hiperinsülinemi ile açklanamamaktadır. Elbette PKOS hastalarında hiperinsülineminin, androjen üretimine katkısı vardır ancak daha farklı mekanizmaların da araştırılmaı gerekir.

🔖

Cite This Article

TOK, E., ERTUNÇ, D., AKTAŞ, A., DİLEK, S. (2004). Evaluation of the effects of obesity and polycystic ovary syndrome on glucose metabolism and sex hormone levels. Türk Fertilite Dergisi, Cilt: 12 - Sayı: 4, 322–328. https://ajindex.com/articles/418774

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333:853-61
  2. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50:113-6
  3. Dunaif A, Graf M, Mandeli J, Laumas V, Dobrjansky A. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia. J Clin Endocrinol Metab 1987;65:499-507
  4. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SS. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996;81:2854-64
  5. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
  6. Vrbikova J, Hill M, Starka L ve ark. The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. Eur J Endocrinol 2001;144:619-28
  7. Ehrmann DA, Sturis J, Byrne MM, Karrison T, Rosenfield RL, Polonsky KS. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus. J Clin Invest 1995;96:520-7
  8. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992;41:1257-66
  9. Polonsky K, Jaspan J, Pugh W ve ark. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction. J Clin Invest 1983;72:1114-23
  10. Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L. Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 2002;25:1217-22
  11. Gennarelli G, Holte J, Berglund L, Berne C, Massobrio M, Lithell H. Prediction models for insulin resistance in the polycystic ovary syndrome. Hum Reprod 2000;15:2098-102
  12. Paradisi R, Venturoli S, Pasquali R ve ark. Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease. J Endocrinol Invest 1986;9:139-44
  13. Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secreti- on in the polycystic ovary syndrome. J Clin Endocrin